Nicholas Investment Partners’s Spyre Therapeutics SYRE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-89,962
Closed -$3.41M 235
2024
Q1
$3.41M Buy
+89,962
New +$3.41M 0.35% 107